Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tankovic

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|May 1, 1997
Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniaeB Perichon, J Tankovic, P Courvalin
Microbial Drug Resistance (Larchmont, N.Y.)|September 24, 2004
CdeA of Clostridium difficile, a new multidrug efflux transporter of the MATE familyL Dridi, J Tankovic, J-C Petit
Microbial Drug Resistance (Larchmont, N.Y.)|February 13, 1999
Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coliR Bachoual, J Tankovic, C J Soussy
FEMS Immunology and Medical Microbiology|June 1, 1994
Construction of a gyrA plasmid for genetic characterization of fluoroquinolone-resistant Staphylococcus aureusJ Tankovic, J Duval, P Courvalin
Antimicrobial Agents and Chemotherapy|April 1, 1993
Antimicrobial susceptibility of Pediococcus spp. and genetic basis of macrolide resistance in Pediococcus acidilactici HM3020J Tankovic, R Leclercq, J Duval
Microbial Drug Resistance (Larchmont, N.Y.)|October 1, 1996
Quinolone resistance mutations in the gyrA gene of clinical isolates of SalmonellaS Ouabdesselam, J Tankovic, C J Soussy
Antimicrobial Agents and Chemotherapy|May 1, 1994
In vivo selection during pefloxacin therapy of a mutant of Staphylococcus aureus with two mechanisms of fluoroquinolone resistanceJ Tankovic, N Desplaces, J Duval, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitroJ Tankovic, B Perichon, J Duval, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Roles of gyrA mutations in resistance of clinical isolates and in vitro mutants of Bacteroides fragilis to the new fluoroquinolone trovafloxacinR Bachoual, L Dubreuil, C J Soussy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2001
Gonococcemia associated with fatal septic shockG Thiéry, J Tankovic, C Brun-Buisson, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|May 1, 1997
Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniaeB Perichon, J Tankovic, P Courvalin
Microbial Drug Resistance (Larchmont, N.Y.)|September 24, 2004
CdeA of Clostridium difficile, a new multidrug efflux transporter of the MATE familyL Dridi, J Tankovic, J-C Petit
Microbial Drug Resistance (Larchmont, N.Y.)|February 13, 1999
Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coliR Bachoual, J Tankovic, C J Soussy
FEMS Immunology and Medical Microbiology|June 1, 1994
Construction of a gyrA plasmid for genetic characterization of fluoroquinolone-resistant Staphylococcus aureusJ Tankovic, J Duval, P Courvalin
Antimicrobial Agents and Chemotherapy|April 1, 1993
Antimicrobial susceptibility of Pediococcus spp. and genetic basis of macrolide resistance in Pediococcus acidilactici HM3020J Tankovic, R Leclercq, J Duval
Microbial Drug Resistance (Larchmont, N.Y.)|October 1, 1996
Quinolone resistance mutations in the gyrA gene of clinical isolates of SalmonellaS Ouabdesselam, J Tankovic, C J Soussy
Antimicrobial Agents and Chemotherapy|May 1, 1994
In vivo selection during pefloxacin therapy of a mutant of Staphylococcus aureus with two mechanisms of fluoroquinolone resistanceJ Tankovic, N Desplaces, J Duval, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitroJ Tankovic, B Perichon, J Duval, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Roles of gyrA mutations in resistance of clinical isolates and in vitro mutants of Bacteroides fragilis to the new fluoroquinolone trovafloxacinR Bachoual, L Dubreuil, C J Soussy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2001
Gonococcemia associated with fatal septic shockG Thiéry, J Tankovic, C Brun-Buisson, et al.
Pageof 4